Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Semerano

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Joint Bone Spine|December 29, 2015
Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four casesSalima Challal, Luca Semerano, Hilario Nunes, et al.
Joint Bone Spine|August 14, 2022
The exposome in rheumatoid arthritisJerome Biton, Nathalie Saidenberg-Kermanac'h, Patrice Decker, et al.
Annals of the Rheumatic Diseases|April 13, 2011
Diurnal variation of power Doppler in metacarpophalangeal joints of patients with rheumatoid arthritis: a preliminary studyLuca Semerano, Marwin Gutierrez, Géraldine Falgarone, et al.
Joint Bone Spine|February 23, 2002
Fibromyalgia in Italian patients with primary Sjögren's syndromePierantonio Ostuni, Costantino Botsios, Paolo Sfriso, et al.
Clinical and Experimental Rheumatology|February 25, 2011
What predicts initiation of osteoporosis treatment after fractures: education organisation or patients' characteristics?Luca Semerano, Xavier Guillot, Maurizio Rossini, et al.
Seminars in Arthritis and Rheumatism|May 30, 2019
High prevalence of spondyloarthritis in sarcoidosis patients with chronic back painJohanna Sigaux, Luca Semerano, Toufik Nasrallah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritisJérôme Biton, Luca Semerano, Laure Delavallée, et al.
Orphanet Journal of Rare Diseases|March 12, 2015
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide surveyLinda Rossi-Semerano, Bruno Fautrel, Daniel Wendling, et al.
Arthritis Research & Therapy|December 25, 2009
Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritisLaure Delavallée, Luca Semerano, Eric Assier, et al.
Journal of Autoimmunity|February 2, 2019
Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37Matthieu Ribon, Sarra Seninet, Julie Mussard, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Joint Bone Spine|December 29, 2015
Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four casesSalima Challal, Luca Semerano, Hilario Nunes, et al.
Joint Bone Spine|August 14, 2022
The exposome in rheumatoid arthritisJerome Biton, Nathalie Saidenberg-Kermanac'h, Patrice Decker, et al.
Annals of the Rheumatic Diseases|April 13, 2011
Diurnal variation of power Doppler in metacarpophalangeal joints of patients with rheumatoid arthritis: a preliminary studyLuca Semerano, Marwin Gutierrez, Géraldine Falgarone, et al.
Joint Bone Spine|February 23, 2002
Fibromyalgia in Italian patients with primary Sjögren's syndromePierantonio Ostuni, Costantino Botsios, Paolo Sfriso, et al.
Clinical and Experimental Rheumatology|February 25, 2011
What predicts initiation of osteoporosis treatment after fractures: education organisation or patients' characteristics?Luca Semerano, Xavier Guillot, Maurizio Rossini, et al.
Seminars in Arthritis and Rheumatism|May 30, 2019
High prevalence of spondyloarthritis in sarcoidosis patients with chronic back painJohanna Sigaux, Luca Semerano, Toufik Nasrallah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritisJérôme Biton, Luca Semerano, Laure Delavallée, et al.
Orphanet Journal of Rare Diseases|March 12, 2015
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide surveyLinda Rossi-Semerano, Bruno Fautrel, Daniel Wendling, et al.
Arthritis Research & Therapy|December 25, 2009
Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritisLaure Delavallée, Luca Semerano, Eric Assier, et al.
Journal of Autoimmunity|February 2, 2019
Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37Matthieu Ribon, Sarra Seninet, Julie Mussard, et al.
Pageof 8